- £170.36bn
- £189.78bn
- $54.07bn
- 96
- 18
- 84
- 77
REG - Redx Pharma Limited - Phase 1 Data on RXC008 Presented at ECCO
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - Directorate Change
AnnouncementREG - AstraZeneca PLC - Final Results
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Imfinzi recommended for EU approval for LS-SCLC
AnnouncementREG - AstraZeneca PLC - Enhertu approved in US for breast cancer post ET
AnnouncementREG - AstraZeneca PLC - Dato-DXd approved in US for HR+ breast cancer
AnnouncementREG - AstraZeneca PLC - Calquence combination approved in US for 1L MCL
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Dato-DXd NSQ NSCLC application withdrawn in EU
AnnouncementREG - AstraZeneca PLC - Tagrisso approved in EU based on LAURA trial
AnnouncementREG - AstraZeneca PLC - Directorate Change
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in US for limited-stage SCLC
AnnouncementREG - AstraZeneca PLC - AstraZeneca appoints Iskra Reic EVP International
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
Announcement